This study has indicated that HMGB1-mediated YAP activation contributes to PFKFB3 upregulation and PASMC glycolysis, which promotes PASMC proliferation, pulmonary vascular remodeling, and ultimately the development of PAH. The gene discussed is HMGB1; the disease is pulmonary arterial hypertension.